It is estimated that 2% of patients with IBS carry mutations in SCN5A, most of which are loss-of-function mutations and are primarily associated with constipation, in contrast to diarrhea-predominant subtypes in patients with IBS [26,27]. Here, SCN5A is linked to irritable bowel syndrome.